2cnf
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Structural Insights into the Design of Nonpeptidic Isothiazolidinone- Containing Inhibitors of Protein Tyrosine Phosphatase 1B== | ==Structural Insights into the Design of Nonpeptidic Isothiazolidinone- Containing Inhibitors of Protein Tyrosine Phosphatase 1B== | ||
- | <StructureSection load='2cnf' size='340' side='right' caption='[[2cnf]], [[Resolution|resolution]] 2.20Å' scene=''> | + | <StructureSection load='2cnf' size='340' side='right'caption='[[2cnf]], [[Resolution|resolution]] 2.20Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[2cnf]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2CNF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2CNF FirstGlance]. <br> | <table><tr><td colspan='2'>[[2cnf]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2CNF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2CNF FirstGlance]. <br> | ||
Line 15: | Line 15: | ||
Check<jmol> | Check<jmol> | ||
<jmolCheckbox> | <jmolCheckbox> | ||
- | <scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/cn/2cnf_consurf.spt"</scriptWhenChecked> | + | <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/cn/2cnf_consurf.spt"</scriptWhenChecked> |
<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | ||
<text>to colour the structure by Evolutionary Conservation</text> | <text>to colour the structure by Evolutionary Conservation</text> | ||
Line 30: | Line 30: | ||
</div> | </div> | ||
<div class="pdbe-citations 2cnf" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 2cnf" style="background-color:#fffaf0;"></div> | ||
+ | |||
+ | ==See Also== | ||
+ | *[[Tyrosine phosphatase|Tyrosine phosphatase]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
Line 35: | Line 38: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
+ | [[Category: Large Structures]] | ||
[[Category: Protein-tyrosine-phosphatase]] | [[Category: Protein-tyrosine-phosphatase]] | ||
[[Category: Ala, P J]] | [[Category: Ala, P J]] |
Revision as of 07:32, 21 August 2019
Structural Insights into the Design of Nonpeptidic Isothiazolidinone- Containing Inhibitors of Protein Tyrosine Phosphatase 1B
|
Categories: Human | Large Structures | Protein-tyrosine-phosphatase | Ala, P J | Becker-Pasha, M | Burn, T C | Combs, A P | Crawley, M L | Douty, B | Glass, B | Gonneville, L | Hillman, M | Hollis, G F | McLaughlin, E | Polam, P | Sparks, R B | Takvorian, A | Wayland, B | Wynn, R | Yue, E W | Acetylation | Endoplasmic reticulum | Hydrolase | Oxidation | Phosphatase | Phosphorylation | Polymorphism | Protein phosphatase